Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy.

Front Surg · 2023 · PMC10106678 · PMID 37077865

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significantp = 0.055so close (0.05 < p ≤ 0.1)

The difference between the ECF/ECX and FLOT treatments in the achievement of R0 and R1 resection was borderline significant (Fisher's exact test; p = 0.055) ( Table 7 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.